Q

Quoin Pharmaceuticals Ltd
NASDAQ:QNRX

Watchlist Manager
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Watchlist
Price: 0.585 USD -5.65% Market Closed
Market Cap: 3m USD
Have any thoughts about
Quoin Pharmaceuticals Ltd?
Write Note

Quoin Pharmaceuticals Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Quoin Pharmaceuticals Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Q
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Other Long-Term Assets
$300k
CAGR 3-Years
82%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Compugen Ltd
NASDAQ:CGEN
Other Long-Term Assets
$1.6m
CAGR 3-Years
-5%
CAGR 5-Years
19%
CAGR 10-Years
32%
B
Biolight Life Sciences Ltd
TASE:BOLT
Other Long-Term Assets
â‚Ş251k
CAGR 3-Years
-37%
CAGR 5-Years
-46%
CAGR 10-Years
10%
No Stocks Found

Quoin Pharmaceuticals Ltd
Glance View

Market Cap
3m USD
Industry
Life Sciences Tools & Services

Quoin Pharmaceuticals Ltd. is a specialty pharmaceutical company engaged in the development of therapeutic products for the treatment of rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.

QNRX Intrinsic Value
2.695 USD
Undervaluation 78%
Intrinsic Value
Price
Q

See Also

What is Quoin Pharmaceuticals Ltd's Other Long-Term Assets?
Other Long-Term Assets
300k USD

Based on the financial report for Jun 30, 2024, Quoin Pharmaceuticals Ltd's Other Long-Term Assets amounts to 300k USD.

What is Quoin Pharmaceuticals Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
27%

Over the last year, the Other Long-Term Assets growth was -21%. The average annual Other Long-Term Assets growth rates for Quoin Pharmaceuticals Ltd have been 82% over the past three years , 27% over the past five years .

Back to Top